AffiliationCRC Department of Medical Oncology, University of Manchester & Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester M20 4BX, UK.
MetadataShow full item record
AbstractCancer is one of the leading causes of death in Western society. Despite improvements in screening, diagnosis and treatment of cancer, many patients ultimately succumb to their disease. Advances in molecular biology and our increased understanding of how the immune system functions have led to an intense interest in the development of cancer vaccines.
CitationVaccines in oncology: background and clinical potential. 2001, 74 (887):991-1002 Br J Radiol
JournalThe British Journal of Radiology
- Next-generation peptide vaccines for advanced cancer.
- Authors: Yamada A, Sasada T, Noguchi M, Itoh K
- Issue date: 2013 Jan
- [HLA-restricted cancer-specific killer T cells].
- Authors: Harada M, Itoh K
- Issue date: 2005 Apr
- Cancer vaccines: finding the best way to train the immune system.
- Authors: Goldman B
- Issue date: 2002 Oct 16
- Anti-tumor vaccination in heterozygous congenic F1 mice: presentation of tumor-associated antigen by the two parental class I alleles.
- Authors: Carmon L, Tzehoval E, Tirosh B, el-Shami KM, Bar-Haim E, Vadai E, Feldman M, Eisenbach L
- Issue date: 2000 May-Jun
- Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo.
- Authors: Tüting T, DeLeo AB, Lotze MT, Storkus WJ
- Issue date: 1997 Oct